- Home
- FCCO vs FBIOP Comparison
FCCO vs FBIOP Comparison
Compare FCCO & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCCO
- FBIOP
- Stock Information
- Founded
- FCCO 1994
- FBIOP N/A
- Country
- FCCO United States
- FBIOP United States
- Employees
- FCCO N/A
- FBIOP 186
- Industry
- FCCO Major Banks
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- FCCO Finance
- FBIOP Health Care
- Exchange
- FCCO Nasdaq
- FBIOP Nasdaq
- Market Cap
- FCCO N/A
- FBIOP N/A
- IPO Year
- FCCO 1998
- FBIOP N/A
- Fundamental
- Price
- FCCO $24.00
- FBIOP $6.61
- Analyst Decision
- FCCO Buy
- FBIOP
- Analyst Count
- FCCO 1
- FBIOP 0
- Target Price
- FCCO $21.00
- FBIOP N/A
- AVG Volume (30 Days)
- FCCO 35.7K
- FBIOP N/A
- Earning Date
- FCCO 01-22-2025
- FBIOP N/A
- Dividend Yield
- FCCO 2.50%
- FBIOP N/A
- EPS Growth
- FCCO 2.46
- FBIOP N/A
- EPS
- FCCO 1.69
- FBIOP N/A
- Revenue
- FCCO $62,732,000.00
- FBIOP N/A
- Revenue This Year
- FCCO N/A
- FBIOP N/A
- Revenue Next Year
- FCCO $11.21
- FBIOP N/A
- P/E Ratio
- FCCO $14.20
- FBIOP N/A
- Revenue Growth
- FCCO 6.16
- FBIOP N/A
- 52 Week Low
- FCCO $15.40
- FBIOP N/A
- 52 Week High
- FCCO $26.48
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- FCCO 35.46
- FBIOP 54.46
- Support Level
- FCCO $24.83
- FBIOP $6.32
- Resistance Level
- FCCO $26.16
- FBIOP $7.10
- Average True Range (ATR)
- FCCO 0.72
- FBIOP 0.67
- MACD
- FCCO -0.31
- FBIOP -0.03
- Stochastic Oscillator
- FCCO 1.59
- FBIOP 61.01
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.